Clinical Trials Logo

Clinical Trial Summary

Observe palonosetron hydrochloride capsules'(Ruo Shan®) safety and efficacy information in the real world using.


Clinical Trial Description

Observe palonosetron hydrochloride capsules'(Ruo Shan®) safety and efficacy information in the real world using.

1. Observe the adverse effects of palonosetron hydrochloride capsules(Ruo Shan®) that we already known, and whether there is any new adverse effects.Observe the incidence and the situation of adverse effects. Pay attention to the adverse effects in special groups, like pregnant women, children, elderly patients, and patients with liver and kidney dysfunction. Observe other safety issues related to drug using method, drug packaging method and drug quality.

[Time Frame: A period between the first day of using Palonosetron Hydrochloride Capsules (Ruo Shan®) to the fifth day]

Secondary Outcome Measures:

2. Furtherly clarify the efficacy of palonosetron hydrochloride capsules, and the widely used population characteristics, and clinical using features of palonosetron hydrochloride capsules.

[Time Frame: A period between the first day of using Palonosetron Hydrochloride Capsules (Ruo Shan®) to the fifth day] ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03148704
Study type Observational
Source Cttq
Contact zheng bo
Phone 18136659876
Email jtuu@163.com
Status Recruiting
Phase N/A
Start date March 8, 2017
Completion date June 8, 2018

See also
  Status Clinical Trial Phase
Completed NCT02809378 - The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV Phase 4
Completed NCT04461093 - Comparison of the Efficacy of Acupressure P6 Point, Dexamethasone and Ondansetron Versus Palonosetron Monotherapy for Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgery N/A
Completed NCT01650961 - The Effect of Palonosetron on the QTc Interval During Perioperative Period N/A